JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 3 465-468
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bar-Shalom, R.
Right arrow Articles by Front, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bar-Shalom, R.
Right arrow Articles by Front, D.

Gallium-67 Uptake in a Mass of Benign Transformation Mimicking Recurrence of Nodular Lymphocytic Predominance Hodgkin's Disease

Rachel Bar-Shalom, Yehudith Ben-Arie, Diana Gaitini, Ron Epelbaum, Steven Parmett, Ora Israel and Dov Front

Departments of Nuclear Medicine, Pathology, Radiology and Oncology, Rambam Medical Center
B. Rappaport Faculty of Medicine, Technion—Israel Institute of Technology, Haifa, Israel

Correspondence: For correspondence and reprints contact: Dov Front, MD, PhD, Department of Nuclear Medicine, Rambam Medical Center, Haifa 35254, Israel.

ABSTRACT

Gallium-67 is now widely used in the management of lymphoma patients. It is not, however, tumor-specific and reasons for up take in nonmalignant and premalignant lesions associated with lymphoma should be recognized.Gallium-67 uptake in a mass of progressively transformed germinal centers and sarcoid-like reaction, mimicking recurrence in a 31-yr-old man with nodular lymphocytic predominance Hodgkin's disease, is described. Gallium-67 was taken up on two occasions and a recurrence was suspected. On the first occasion, abnormal uptake was present in axillary lymphnodes and on the second in mediastinal and parahilar lymphnodes. Histology of the lesions on both occasions showed progressively transformed germinal centers and sarcoid-like reaction but no evidence of Hodgkin's disease (HD). Bilateral parahilar abnormal uptake of 67Ga disappeared spontaneously without treatment after several months. The mass on CT regressed but did not disappear. This case demonstrates that the appearance of a new mass which takes up 67Ga in lymphocytic-predominance HD during a continuous clinical remission does not necessarily indicate recurrence and the need for treatment. It suggests that a biopsy should be performed to determine the nature of the lesion.

Key Words: gallium-67 scintigraphy • lymphoma







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.